Skip to main content
. 2009 Jul 28;339:b2548. doi: 10.1136/bmj.b2548

graphic file with name shal570267.f2_default.jpg

Fig 2 Cumulative proportion of women developing cervical intraepithelial neoplasia grade II or more severe disease from trial recruitment up to and including exit examination, by trial arm (χ2 from log rank test)